仝战旗,杨波,童新元,龚琴,陈丙跃,吴整军.复方苦参结肠溶胶囊治疗湿热内蕴型溃疡性结肠炎多中心、随机、双盲、对照研究[J].,2011,31(2):172-175 |
复方苦参结肠溶胶囊治疗湿热内蕴型溃疡性结肠炎多中心、随机、双盲、对照研究 |
A Multi-center Randomized Double-blinded, Placebo-controlled Clinical Study on Efficacy of Composite Sophora Colon-soluble Capsules in Treating Ulcerative Colitis of Internal Dampness-Heat Accumulation Syndrome Type |
|
DOI: |
中文关键词: 复方苦参结肠溶胶囊 美沙拉嗪缓释颗粒 溃疡性结肠炎 湿热内蕴证 多中心临床试验 |
英文关键词:Composite Sophora Colon-soluble Capsules mesalazine slow releasing granule ulcerative colitis internal dampness-heat accumulation syndrome multi-center clinical trial |
基金项目: |
仝战旗 杨波 童新元 龚琴 陈丙跃 吴整军 |
1.解放军总医院南楼中医针灸科(北京100853) ; 2.北京中惠药业有限公司(北京100094) ; 3.解放军总医院医学统计教研室(北京100853)
|
Hits: 1908 |
Download times: 3 |
中文摘要: |
目的 观察复方苦参结肠溶胶囊治疗溃疡性结肠炎(ulcerative colitis, UC)湿热内蕴证的临床疗效及安全性,并同美沙拉嗪缓释颗粒(艾迪莎)进行比较。 |
英文摘要: |
Objective To evaluate the clinical efficacy and safety of Composite Sophora Colon-soluble Capsules (CSCC) in treating patients with ulcerative colitis (UC) of internal dampness-heat syndrome type (IDHS) and compared with that of Mesalazine slow releasing granules (trade name:Etiasa). Methods Adopting randomized double-blinded double-simulated and positive drug controlled clinical design,160 patients with UC of IDHS type were randomly assigned to two groups,120 in the trial group was treated with CSCC plus E... |
View Full Text View/Add Comment Download reader |